Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bleyer WA, O’Leary M, Barr R, Ries LAG (eds) (2006) Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival, 1975–2000. National Cancer Institute, NIH Pub. No. 06-5767. Bethesda, MD
McMahon B (1957) Epidemiological evidence on the nature of Hodgkin Disease. Cancer 10:1045–1054
O’Leary M, Sheaffer JW, Keller FG, et al (2006) Lymphomas and reticuloendothelial neoplasms. In: Bleyer WA, O’Leary M, Barr R, Ries LAG (eds) Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, including SEER Incidence and Survival, 1975–2000. National Cancer Institute, NIH Pub. No. 06-5767. Bethesda, MD
Mueller NE, Grufferman S (1999) The epidemiology of Hodgkin Disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM (eds) Hodgkin Disease. Lippincott Williams & Wilkins, Philadelphia, pp 61–78
Sleckman BG, Mauch PM, Ambinder RF, et al (1998) Epstein-Barr virus in Hodgkin disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection. Cancer Epidemiol Biomarkers Prev 7:1117–1121
Glaser SL, Lin RJ, Stewart SL, et al (1997) Epstein-Barr virus-associated Hodgkin disease: epidemiologic characteristics in international data. Int J Cancer 70:375–382
Chang ET, Montgomery SM, Richiardi L, et al (2004) Number of siblings and risk of Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 13:1236–1243
Chang ET, Zheng T, Weir EG, et al (2004) Childhood social environment and Hodgkin lymphoma: new findings from a population-based case-control study. Cancer Epidemiol Biomarkers Prev 13:1361–1370
Ambinder RF, Weiss LM (1999) Association of Epstein-Barr virus with Hodgkin disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM (eds) Hodgkin Disease. Lippincott Williams & Wilkins, Philadelphia, pp 79–100
Henderson BE, Dworsky R, Pike MC, et al (1979) Risk factors for nodular sclerosis and other types of Hodgkin Disease. Cancer Res 39:4507–4511
Jarrett RF (2003) Risk factors for Hodgkin lymphoma by EBV status and significance of detection of EBV genomes in serum of patients with EBV-associated Hodgkin lymphoma. Leuk Lymphoma 44:S27–32
Hjalgrim H, Askling J, Rostgaard K, et al (2003) Characteristics of Hodgkin lymphoma after infectious mononucleosis. N Engl J Med 349:1324–1332
Thorley-Lawson DA, Gross A (2004) Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350:1328–1337
Goldin LR, Pfeiffer RM, Gridley G, et al (2004) Familial aggregation of Hodgkin lymphoma and related tumors. Cancer 100:1902–1908
Mack TM, Cozen W, Shibata DK, et al (1995) Concordance for Hodgkin disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 332:413–418
Staratschek-Jox A, Shugart YY, Strom SS, et al (2002) Genetic susceptibility to Hodgkin lymphoma and to secondary cancer: workshop report. Ann Oncol 13:30–33
Calza L, Manfredi R, Colangeli V, et al (2003) Hodgkin disease in the setting of human immunodeficiency virus infection. Scand J Infect Dis 35:136–141
Westergaard T, Melbye M, Pedersen JB, et al (1997) Birth order, sibship size and risk of Hodgkin disease in children and young adults: a population-based study of 31 million person-years. Int J Cancer 72:977–981
Harris NL (1999) Hodgkin lymphomas: classification, diagnosis, and grading. Semin Hematol 36:220–232
Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P (2005) International Classification of Childhood Cancer, third edition. Cancer 103:1457–1467
Landman-Parker J, Pacquement H, Leblanc T, et al (2000) Localized childhood Hodgkin disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy — results of the French Society of Pediatric Oncology Study MDH90. J Clin Oncol 18:1500–1507
Lobo-Sanahuja F, Garcia I, Barrantes JC, et al (1994) Pediatric Hodgkin disease in Costa Rica: twelve years experience of primary treatment by chemotherapy alone, without staging laparotomy. Med Pediatr Oncol 22:398–403
Smith M, Gurney J, Ries L (1999) Cancer among adolescents 15–19 years old. In: Ries LAG (ed) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995. National Cancer Institute, Bethesda, MD, pp 157–164
Selby P, Pate P, Milan S, et al (1990) ChlVPP combination chemotherapy for Hodgkin disease: long-term results. Br J Cancer 62:279–285
Nachman JB, Sposto R, Herzog P, et al (2002) Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin disease who achieve a complete response to chemotherapy. J Clin Oncol 20:3765–3771
Laskar S, Gupta T, Vimal S, et al (2004) Consolidation radiation after complete remission in Hodgkin disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need? J Clin Oncol 22:62–68
Donaldson SS, Hudson MM, Lamborn KR, et al (2002) VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin disease: results of a prospective clinical trial. J Clin Oncol 20:3081–3087
Schellong G, Potter R, Bramswig J, et al (1999) High cure rates and reduced long-term toxicity in pediatric Hodgkin disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin Disease Study Group. J Clin Oncol 17:3736–3744
Yung L, Smith P, Hancock BW, et al (2004) Long-term outcome in adolescents with Hodgkin lymphoma: poor results using regimens designed for adults. Leuk Lymphoma 45:1579–1585
Ng AK, Bernardo MVP, Weller E, et al (2002) Second malignancy after Hodgkin Disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 100:1989–1996
Hancock SL, Donaldson SS, Hoppe RT (1993) Cardiac disease following treatment of Hodgkin disease in children and adolescents. J Clin Oncol 11:1208–1215
Bhatia S, Yasui Y, Robison LL, et al (2003) High risk of subsequent neoplasms continues with extended followup of childhood Hodgkin disease: report from the Late Effects Study Group. J Clin Oncol 21:4386–4394
Herbertson R, Hancock BW (2005) Hodgkin lymphoma in adolescents. Cancer Treatment Rev 31:339–360
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Trippett, T.M., Mottl, A., Oberlin, O., Bleyer, A., Constine, L.S. (2007). Hodgkin Lymphoma. In: Bleyer, W.A., Barr, R.D. (eds) Cancer in Adolescents and Young Adults. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68152-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-540-68152-6_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-40842-0
Online ISBN: 978-3-540-68152-6
eBook Packages: MedicineMedicine (R0)